| Revenue growth | 9.4% YoY for Q4 FY26; 4.8% for full year FY26. |
|---|---|
| Margins | Consolidated EBITDA margin stable at 14.5% for FY26. |
| Demand visibility | Strong; ~3.5 million patients served since inception. |
| Management confidence | High focus on Arthroplasty leadership and technology-led homecare expansion. |
Growth
FY26 Consolidated Revenue up 4.8% to ₹11,682 mn; FY26 PAT grew 1706% to ₹347 mn due to tax adoption.
Outlook
Targeting 200-bed Asha Parekh Hospital by 2030-31; focusing on doubling ROCE via operational leverage and asset-light expansion.
Risks
International segment (Shalby International) reported EBITDA losses of ₹42 mn for FY26; hospital occupancy remains low at 48%.
Earnings Call filed with NSE, NSE: SHALBY. Summary written with AI assistance from the document.
Shalby Ltd: key numbers
- Share price
- ₹135.00
- Market cap
- ₹1,458 Cr
- Revenue (annual)
- ₹1,141 Cr
- Net profit (annual)
- ₹37.39 Cr
- P/E (TTM)
- 37.1×Sector 53.1×
- Promoter holding
- 74.33%+0.00% QoQ
- FII holding
- 4.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shalby Ltd
All →Shalby Management Change
Shareholders at the AGM did not approve the appointment of Mr. Shanay Vikram Shah as Director, resulting in his cessation from the Board effective September 10, 2026.
Shalby Annual General Meeting
Shalby Limited held its 22nd Annual General Meeting on September 10, 2026. The meeting covered adoption of financial statements and appointment of a whole-time director.
Shalby Other Announcement
Shalby Limited has issued a letter to shareholders providing the web-link for the Annual Report for FY 2025-26. The 22nd Annual General Meeting is scheduled for September 10, 2026.
Shalby Business Update
Shalby Limited filed its Business Responsibility & Sustainability Report (BRSR) for FY 2025-26 as mandated by SEBI LODR regulations.
Shalby Annual General Meeting
Shalby Ltd announced its 22nd Annual General Meeting scheduled for September 10, 2026, and filed its Annual Report for FY 2025-26.
Shalby Earnings Call Transcript: Key Takeaways
Shalby reported a modest 11.6% revenue growth with its MetLife business reaching EBITDA break-even, but hospital margins remain under pressure due to new doctor recruitments.
- Call
- Guides 20% growth